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Abstract
A general approach for discovering novel catabolic metabolites from a parent biocompound was
developed and validated on metabolism of γ-tocopherol in human A549 cell. Method is based on
LC-MS analysis of in vitro stable isotope labeled metabolites and assumes that a parent compound
and its metabolites share a common functional group that can be derivatized by well-documented
reagents. In this method, two equal aliquots of extracted metabolites are separately derivatized with
isotope-coded (heavy) and non-isotope-coded (light) form of derivatizing reagent, mixed at 1:1 ratio
and analyzed using LC-MS. The metabolites with common functional group are then easily
recognized by determination of a chromatographically co-eluted pair of isotopomers (MS doublet
peaks) with similar peak intensities and mass difference corresponding to the mass difference
between heavy and light form of derivatization reagent. The feasibility of this approach was
demonstrated and validated by identification of products of γ-tocopherol catabolism in human A549
cell culture media using N-methyl-nicotinic acid N-hydroxysuccinimide ester (C1-NANHS) and N-
methyl-d3-nicotinic acid N-hydroxysuccinimide ester (C1-d3-NANHS) derivatizing reagent.
Overall four γ-tocopherol metabolites were identified including 9'-COOH, 11'-COOH, 13'-COOH
and 13'-OH. In addition, the developed LC-MS method can also be used for the fast and sensitive
quantitative analysis of γ-tocopherol and other forms of vitamin E related compounds.
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1. Introduction
Metabolites are important indicators of biological processes, and discovery of new metabolites
and determination of their concentration levels may provide insight into disease mechanisms,
metabolic pathway interaction, and metabolism and absorption process of drugs. With recent
advances in analytical methodology such as the use of ultra-performance liquid
chromatography-high resolution mass spectrometry (UPLC-HRMS) and with increasing
number of commercially available standards the confirmation or quantification of known
metabolites becomes integrated part of many analytical laboratories. On the other hand due to
high complexity of biological systems initial discovery of novel endogenous metabolites still
remains a challenging aspect of biology. Traditionally, discovery of new metabolites from a
single parent molecule was performed by tracking radioactive tracers that are catabolized from
a radioactive parent compound [1,2]. Although well accepted, this approach is difficult to apply
to the studies on human subjects. Another widely used approach is in vivo stable isotope
labeling. Stable isotope labels (most often 13C) are incorporated into metabolites in the
metabolism process through feeding the biological reference sample with isotope labeled
media, such as 13C-glucose or 13C-acetate. Metabolites are discovered and quantified through
comparing the profiling of isotope labeled and non-isotope labeled samples by means of
differential analytical techniques, such as MS and NMR [3,4]. While this approach can be used
in more complicated metabolic systems, it is again unsuitable for living organisms. Currently,
a prevailing approach in biomarker discovery is in vitro differential labeling technique, such
as two-color nucleotide labeling by fluorescent probes [5,6] in transcriptomics, protein
fluorescence labeling [7,8], isotope-coded affinity tag (ICAT) [9,10] and global internal
standard technology (GIST) [11,12] in proteomics. Whilst protein or RNA molecules have
common chemical moieties that can be universally labeled, in metabolome analyses
comprehensive labeling technologies areimpossible because of the high chemical diversity of
metabolites. Yet, similar applications of this technique to metabolites have also been exploited
through technique called Group Specific Internal Standard Technology (GSIST) [13–17].
Similarly, isotope-coded glutathione has been utilized as trapping reagent for identification of
reactive drug metabolites. The pitfall is that this reagent only works for electrophilic
compounds [18].
LC-MS is currently a dominant analytical tool for metabolite quantification and identification.
Recently the introduction of high mass accuracy and high resolution mass spectrometers has
increased the quality of acquired data. In addition, the use of various scan modes for data
acquisition including precursor ion and neutral loss scans, and advanced data-processing
approaches such as mass defect filter [19] or multivariate statistical analysis [20] significantly
improved metabolite detection. In order to further simplify and streamline the identification
process of novel metabolites, we developed a new LC-MS approach which is based on in
vitro differential stable isotope labeling. Method was evaluated and validated by determination
of the intermediates of γ-tocopherol catabolism.
γ-tocopherol represents the most biologically relevant form of vitamin E in many diets and
provides antioxidant activities through electron trapping of lipophilic electrophiles and reactive
nitrogen and oxygen species [21] Plasma γ-tocopherol has been shown to be inversely
associated with the risk of prostate cancer and coronary heart diseases [21]. The first metabolite
of γ-tocopherol, 7,8-dimethyl-2-(β-carboxyethyl)-6-hydroxychromanol (γ-CEHC), was
isolated from human urine in 1996 [22,23]. The structure of γ-CEHC suggests that it is
metabolized via phytyl chain oxidation of γ-tocopherol, without oxidative modification of the
chroman ring. A cytochrome P450 ω-hydroxylase pathway of γ-tocopherol catabolism was
elucidated in 2002 [24,25]. The pathway involves cytochrome P450-mediated ω-hydroxylation
of the tocopherol phytyl side chain followed by stepwise removal of two- or three- carbon
moieties, ultimately yielding γ-CEHC, as shown in Figure 1. Recently, several novel sulfuric
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acid conjugates of γ-tocopherol metabolites were reported [26] and some intermediate
metabolites have been shown to be potent inhibitors for cyclooxygenases [27]. The same
mechanism of γ-tocopherol side-chain degradation was also reported in other cells, such as
HepG2 cells [28]. However, except for γ-CEHC, all other intermediates have been readily
available for use in metabolic studies and therefore they have not been further confirmed with
radioactive or stable isotope-labeled forms of γ-tocopherol or by direct comparison with the
authentic compounds.
In this work, these metabolites were validated by the proposed method without the use of
radioactive or stable isotope-labeled forms of γ-tocopherol, or standard metabolites of γ-
tocopherol.
2. Experimental
2.1 Chemicals and reagents
Triethylamine (TEA) and γ-tocopherol were obtained from Sigma (St. Louis, MO). HPLC
grade acetonitrile and formic acid were purchased from Mallinkrodt Baker (Phillipsburg, NJ)
and 7,8-dimethyl-2-(β-carboxyethyl)-6-hydroxychromanol (γ-CEHC) from Cayman
Chemicals (Ann Arbor, MI). Double-deionized water was produced by a Milli-Q gradient A10
system from Millipore (Bedford, MA).
Derivatizing reagents, N-methyl-nicotinic acid N-hydroxysuccinimide ester (C1-NANHS) and
N-methyl-d3-nicotinic acid N-hydroxysuccinimide ester (C1-d3-NANHS), were synthesized
as described by Yang et al. [14]. Briefly, nicotinic acid was first esterificated by N-
hydroxysuccinimide through the activation of dicyclohexylcarbodiimide (DCC) to form
nicotinic acid N-hydroxysuccinimide ester, which was further quaternized by iodomethane or
iodomethane-d3.
2.2 Cell culture for catabolism study of γ-tocopherol
The human alveolar epithelial cell line A549 was obtained from American Type Culture
Collection (Manassas, VA). Cells were maintained routinely in RPMI-1640 with 10% fetal
bovine serum (FBS). At the time of experiments, cells were seeded in RPMI-1640 with 10%
FBS at a density of 8×105 cells per well in 6-well plates. Twenty-four hours later, media were
replaced with fresh DMEM containing 1% FBS with either 50 μM γ-tocopherol in dimethyl
sulfoxide (DMSO; stored in −20 °C) (experimental samples) or 0.05% DMSO (control
samples). After 72 hour incubation, media were collected, frozen immediately and stored in
−20°C until further use. In order to improve detection and identification of γ-tocopherol related
metabolites two additional control samples were generated.
The “non-cell” control samples were obtained by incubation of cell-free DMEM containing
1% FBS in 6-well plates for 72 h.
For “inhibitor” control samples, cells were incubated with DMEM containing 1% FBS, 50 μM
γ-tocopherol and 0.5 μM sesamin in DMSO (stored in −20 °C) for 72h.
2.3. Sample preparation
2.3.1 SPE extraction—A 3-mL C18 SPE cartridge (VYDAC, Deerfield, IL) was
preconditioned with 2 mL of elution solution (99.9% ACN + 0.1% formic acid) and 2.0 mL
of washing solution (5% ACN+0.1% formic acid). Cell culture media (1 mL) was loaded into
the cartridge and washed with 3 mL of the washing solution. The analytes were eluted with 2
mL of the elution solution, split into two equal aliquots, and dried under nitrogen.
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2.3.2 Derivatization—Individual dried aliquotes were resuspended in 50 μL of acetonitrile
containing 25 mg/mL either C1-NANHS or C1-d3-NANHS derivatizing reagent, respectively.
Following an addition of 1 μl TEA the mixture was vortexed for 30 seconds, and the reaction
stopped by 2 μL of formic acid. Light and heavy forms of solutions were mixed at 1:1 ratio,
and directly analyzed by LC-MS.
2.4. LC-ESI-MS
LC experiments were performed with an Agilent XDB-C18 column (4.6 × 50 mm, 1.8 μm
particle size) on Agilent 1100 Series LC system (Agilent Technologies, Wilmington, DE). The
mobile phases were composed of (A) 5% ACN + 0.05% formic acid, and (B) 95% ACN +
0.05% formic acid in water. Separation was achieved by a 30 min linear gradient from 100%
A to 100% B at a flow rate of 1.2 mL/min. Injection volume was 5 μL. System back pressure
did not exceed 200 bars during the analysis.
MS analysis was carried out on Unique® LC-TOFMS with High Flow ESI Source (LECO
Corporation, St. Joseph, MI). The main operation parameters for positive ESI were as follows:
electrospray voltage, 4900 V; desolvation temperature, 370 °C; nebulizer pressure, 400 kPa;
interface temperature, 100 °C; nozzle voltage, 230 V; skimmer voltage, 75 V; quad RF voltage,
250; quad high voltage, 76 V; quad low voltage, 32 V; quad exit voltage, 32 V; desolvation
gas, 6880 mL/min.
2.5. ESI-MS/MS
Tandem MS analysis was performed on a Micromass Q-Tof micro mass spectrometer (Waters,
Milford, MA). Collected fractions from LC separation (0.5 mL) were dried, reconstituted in
0.5 mL of methanol/H2O/formic acid (50%/49.9%/0.1%) and injected into the ESI source by
infusion at 5.0 μL/min. Ionization was achieved with an electrospray voltage of 3 kV, cone
voltage of +30 V, cone and desolvation gas flows of 5–8 and 500 L/h, respectively. The source
block and desolvation temperatures were maintained at 150°C and 350°C, respectively. To
obtain the most relevant MS/MS spectra, collision energy was optimized and established at 45
V.
3. Results
3.1 Strategy for novel metabolite discovery
Most of the metabolites in real biological samples are present at very low concentrations and
their detection requires the use of highly sensitive methods Tocopherol metabolites contain
carboxylic group (Figure 1) suggesting that maximum sensitivity would be achieved by ESI
in negative mode. For revised-phase HPLC separation, small portion of organic acid is typically
added in the mobile phase to maintain separation reproducibility and to extend the lifetime of
a column. This additive may suppress the ionization efficiency of the acidic analytes, and
significantly reduce the detection sensitivity [14]. To circumvent this obstacle, acidic
metabolites can be derivatized with a quaternized derivatizing reagent, C1-NANHS, as it is
illustrated in Figure 2. This derivatization reaction introduces a permanent positive charge to
the analytes by which ESI efficiency and detection sensitivity are greatly increases [13].
Moreover added tag decreases hydrophobicity of derivatized compounds and consequently
reduces their retention time and overall time for the analysis. It is important to note that parent
molecule and its metabolites must carry the same functional group such as phenol moiety in
the case γ-tocopherol catabolism. Metabolites with modified functional group cannot be
derivatized and identified. In addition, products of derivatization reaction must be stable to
give consistent results during LC-MS analysis.
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Although derivatization increases ionization efficiency of tagged molecules, a main challenge
in complex samples is how to differentiate between peaks that correspond to derivatized and
non-derivatized metabolites. Figure 3 shows the analytical ion chromatograms (similar to base
peak chromatogram in some other MS software) of derivatized experimental (Fig. 3A) and
control (Fig. 3B) samples analyzed by LECO Unique MS software (v3.1). Vertical lines in the
chromatograms represent detected chromatographic peaks (even though these peaks are too
small to be seen visually). Overall 90 peaks were detected in experimental and 100 peaks in
control sample. Traditional way to discover metabolite candidates involved in catabolism of
parent molecule is to align chromatograms corresponding to experimental and control samples
using the retention time of individual chromatographic peaks and identify those that are present
in the experimental sample only. This method however depends strongly on reproducibility
and even small change in retention time may lead to false positive/negative identification/
elimination of potential targets. An alternative approach is to reduce the complexity by
recognition of peaks corresponding to tagged metabolites using stable isotope labeling strategy.
3.2 Identification of γ-tocopherol metabolites
The method illustrated in Figure 4 was used to verify various metabolites from γ-tocopherol,
including long-chain carboxychromanols generated in A549 cells [27]. The experimental
sample was split in half and aliquots simultaneously derivatized with C1-NANHS (light form)
or C1-d3-NANHS (heavy form), respectively. The resulting deuterated and non-deuterated
experimental samples were mixed and analyzed by LC-MS. Chromatographic peaks were
detected by LECO Unique MS software and then were examined manually for the presence of
ion doublets. Because all metabolites of γ-tocopherol contain a single phenol group and equal
amount of samples were derivaitzed by the reagents with mass difference of 3 amu, only
doublets with similar intensities and a mass difference of 3 were selected for further analysis.
The control sample was treated and analyzed in same way. The selected ion doublets from both
experimental and control samples were then compared and those detected in both samples
disregarded. The doublets exclusively found in the experimental sample were identified as
potential metabolite of γ-tocopherol catabolism. This conclusion was based on the two facts:
1) cells for experimental and control samples were treated identically except for that the
experimental cells were cultivated in the presence of γ-tocopherol, and 2) γ-tocopherol and its
metabolites contain a single derivatizable functional group. This procedure assured exclusion
of false positive/negative candidates by using these three additional criteria for identification;
derivatization of targeted molecules, mass difference and 1:1 ratio in peak intensities between
light and heavy form of the same compound. Using this screening process, 6 ions with m/z
values of 496.30 (ion 1), 593.32 (ion 2), 621.33 (ion 3), 566.38 (ion 4), 663.40 (ion 5) and
552.40 (ion 6) for non-deuterated derivatization were found uniquely in the experimental
sample (Fig. 5A). None of those ions was detected in the analytical ion chromatogram of the
control, non-γ-tocopherol cell culture media (Fig. 5B). To rule out the possibility that these
ions were from the chemical decomposition of γ-tocopherol during the cell culture process, the
“non-cell” control was also analyzed. As expected γ-tocopherol was the only peak detected
(Fig. 5C). Additional experiments with “inhibitor” control samples also suggested that all
identified ions are metabolites of γ-tocopherol catabolism as the intensities of ion 1 to 6
decreased in the presence of sesamin (Figure 5D). Sesamin, a benzofuran lignan in sesame
seed oil, is known to inhibit γ-tocopherol-ω-hydroxylase [24,25].
3.3 Structural determination of identified ions
The above evidence strongly sugguests that the 6 ion candidates were from γ-tocopherol
catabolism. After subtracting the mass of derivatizing tag (mass is 120.13), the ion 1 (m/z
376.17) matches the metabolite 9'-COOH, ion 4 (m/z 446.25) matches 13'-COOH, and ion 6
(m/z 432.27) matches 13'-OH. No match, however, was found for ions 2, 3, and 5 (Fig. 6).
Further examination revealed that the m/z values of ion 2, 3, and 5 correspond to the derivatized
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9'-COOH, 11'-COOH and 13'-COOH plus the mass addition of 97.02, respectively. This
number represents the mass of N-hydroxysuccinimide (NHS) (Mr 115.09) minus H2O (Mr
18.02). NHS is a by-product of the derivatization and a reactant for synthesizing the derivatizing
reagent. Therefore, we suspected that these ions might be generated from the secondary
derivatization through carboxyl groups of the metabolites and NHS produced in the
derivatizing process of phenol group To verify this hypothesis, a standard metabolite, γ-CEHC,
was derivatized with C1-NANHS and C1-d3-NANHS and the 1:1 mixture was analyzed. As
shown in Figure 7, the expected derivatized ions through phenol group (Peak 1, m/z = 384.14
and 387.17) and a major ions with extra mass of 97.02 (Peak 2, m/z = 481.16 and 484.18)
appeared. In both cases, similar intensities between light and heavy form of the corresponding
ions indicate that they are direct products of derivatization reaction. These results are consistent
with those obtained for ion 2, 3 and 5 and suggest the chemical reaction summarized in Figure
8. Moreover, this ester is unstable under acidic conditions thus by performing the reaction
overnight at room temperature a decrease of original peak 2 and significant increase of the
peak 1 (expected ions) is observed (Fig 7A and B). Reaction between carboxylic group and N-
hydroxysuccinamide (NHS) requires activation of carboxylic group through a coupling
reagent, such as dicyclohexylcarbodiimide. In this case however no coupling reagent is present
and the exact mechanism of the reaction is unclear.
Molecular structures of derivatized γ-tocopherol and secondarily derivatized 13'-COOH (ion
5) were also confirmed by MS/MS analysis (Fig. 9). Corresponding fractions were collected
during LC separation and directly analyzed using tandem mass spectrometry. The MS/MS
fragments originated in precursor molecules can be easily recognized, since they contain
characteristic deuterated and non-deuterated ion doublet pattern (Fig. 9). The similar fragment
to ion m/z 270.1 was previously reported in EI spectra of γ-tocopherol metabolites [25]. The
MS/MS spectrum of ion 5 confirmed the hypothesis of the secondary derivatization. Therefore
six unique ions found in the experimental sample were identified as 4 metabolites of γ-
tocopherol (Table 1).
4. Discussion
The process for discovering a novel metabolite using MS is more difficult than for finding or
confirming a preconceived one. In complex samples, large numbers of ions with wide dynamic
range of concentrations generates many chromatographic peaks varied in peak intensities and
the use of high accuracy/resolution instruments such as TOF-MS, Orbitrap-MS or FT-ICR-
MS is often necessary to identify peaks that may potentially correspond to novel metabolites.
Structural determination and confirmation is then achieved by Q-TOF, Q-Trap, ion trap or
other instruments capable MSn analysis. Even with these mass spectrometers, it may be still
difficult to give unambiguous identification for endogenous metabolites. Ultimately the best
approach would be the synthesis of possible metabolites and direct comparison of the LC-MS
data for the experimentally detected metabolites and synthesized compounds. This approach
is however expensive, time consuming and requires much efforts to conduct the synthesis of
the desired structures. On the other hand, in vitro stable isotope labeling strategy presented in
this paper offers a relatively simple, three steps selection process that increases identification
reliability without synthesis of expensive standards. The first selection step was based on
derivatization presuming that phenol functional group in γ-tocopherol is still remaining in its
catabolic metabolites. Therefore, all metabolites should be derivatized in the same way as the
parent compound. The derivatization also introduced a permanent positive charge on the
derivatives enhancing MS detection sensitivity for the derivatives and suppressing the
ionization of other ions. The second selection step was achieved through isotope coding. This
coding generated a pair of MS isotopomers, which are completely coeluted in a single LC peak,
theoretically equal in peak intensities with mass difference of 3 amu between the light and
heavy form. This feature provided an easy way to visually recognize derivatized compounds
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from MS spectra. The process of doublet recognition and search for characteristic isotope
signature can be also automated using either “in house” developed software [29] or modified,
commercially available programs for MS based metabolite identification. The third selection
step involves direct comparison of experimental and control samples. The compounds which
have passed the first two filters do not necessarily represent a metabolite of interest, since the
derivatization is not absolutely group-specific. For instance, C1-NANHS used in this study for
derivatization of phenol groups can also react with amines. However, through the control
experiments, those deivatized compounds existing in both experimental and control samples
can be eliminated.
The secondary derivatization presented an extra demonstration for the metabolite 13'-COOH,
11'-COOH and 9'-COOH. The finding for the secondary derivatization to carboxyl groups is
also significant as under the normal conditions, NHS reacts with carboxyl groups only in the
presence of an activating reagent. Our data, however, suggest that NHS freshly produced during
a reaction process can immediately react with carboxyl group. This might provide a new way
for the esterification of carboxylic acid. In the previous work, sulfuric acid conjugates of 13'-
COOH, 11'-COOH and 9'-COOH through phenol groups were demonstrated in the human cell
line A549 [26]. These metabolites do not have free phenol groups, and cannot be detected by
described procedure.
Additionally, the LC-MS method developed here provides a fast and sensitive assay for γ-
tocopherol and its metabolites. The enhancement of MS detection sensitivity and the decrease
in separation time through this type of derivatization have been previously reported [13,14].
In this study, the use of a short column with small particle size packing (1.8 μm) further reduced
separation time from ~50min [26] to ~10 min and increased separation efficiency.
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Figure 1.
Metabolic pathway of γ-tocopherol.
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Figure 2.
Derivatization reaction of γ-tocopherol and its metabolites.
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Figure 3.
Analytical ion chromatograms of (A) γ-tocopherol and (B) non-γ-tocopherol control cell
culture media. The vertical lines with numbers indicate the presence of the peaks. Sample
aliquots were derivatized in two separate reactions with C1-NANHSand C1-d3-NANHS, and
mixed at 1:1 ratio for LC-MS analysis. Experimental conditions are described in the
experimental section.
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Figure 4.
Strategy for metabolite discovery.
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Figure 5.
Extracted ion chromatograms (EIC) suggesting the presence of intermediates of γ-tocopherol
catabolism in cell culture media. A: cells incubated in the media with γ-tocopherol; B: cells
incubated in the media without γ-tocopherol; C: cell-free media with γ-tocopherol; D: cells
incubated in the media with γ-tocopherol and catabolism inhibitor sesamin. The numbered
peaks represent the ions which were found uniquely in cell culture media (except for γ-
tocopherol). Dotted and solid lines represent deuterated and non-deuterated derivatives,
respectively. Analytical conditions are described in the experimental section.
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Figure 6.
MS spectra corresponding to peak2, 3, and 5 in Figure 5 A. Experimental conditions are
described in the experimental section.
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Figure 7.
Chromatographic evidences supporting the secondary derivatization reaction. A: EIC of
derivatives analyzed one minute following the derivatization; B: EIC of derivatives analyzed
after overnight reaction at room temperature. Peak 1 - expected derivative; Peak 2 - secondary
derivative. Experimental conditions are described in the experimental section.
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Figure 8.
Derivatizing process of γ-CEHC with suggested secondary reaction.
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Figure 9.
MS/MS spectra of (A) derivatized γ-tocopherol and (B) secondarily derivatized metabolite 13'-
COOH. Experimental conditions are described in the experimental section.
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Table 1
Ions corresponding to metabolites of γ-tocopherol in cell culture media
Observed m/z value of ions Corresponding metabolite
496.30 9'-COOH (mono-derivatized)
593.32 9'-COOH (bis-derivatized)
621.33 11'-COOH (bis-deivatized)
566.38 13'-COOH (mono-derivatized)
663.40 13'-COOH (bis-derivatized)
552.40 13'-OH
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